An inverse association between ovarian cysts and breast cancer in the breast cancer family registry

Ovarian cysts of several types are common in women of reproductive age. Their etiology is not well understood but is likely related to perturbations in the hypothalamic‐pituitary‐gonadal axis. The relationship of ovarian cysts to breast cancer risk is not known, although a negative association with polycystic ovarian syndrome has been reported. Incident, invasive female breast cancer cases, population‐based controls and unaffected sisters of cases were studied from 3 countries participating in the Breast Cancer Family Registry: Melbourne and Sydney, Australia; the San Francisco Bay Area, USA; and Ontario, Canada. Using the same questionnaire, information was collected on self‐reported history of ovarian cysts and other risk factors. Analyses were based on 3,049 cases, 2,344 population controls and 1,934 sister controls from all sites combined. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using both unconditional and conditional logistic regression using an offset term to account for sampling fractions at 2 of the sites. A significantly reduced risk of breast cancer was observed for women reporting a history of ovarian cysts (OR = 0.70, 95% CI 0.59–0.82, among all cases and all controls). This risk estimate was similar regardless of control group used, within all 3 sites and in both premenopausal and postmenopausal women (ORs ranging from 0.68–0.75, all 95% CI excluded 1.00). A self‐reported history of ovarian cysts was strongly and consistently associated with a reduced risk of breast cancer. Further study of ovarian cysts may increase our understanding of hormonal and other mechanisms of breast cancer etiology. © 2005 Wiley‐Liss, Inc.

[1]  D. Guzick Polycystic ovary syndrome. , 2007, Obstetrics and gynecology.

[2]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .

[3]  Norman Boyd,et al.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.

[4]  I. Andrulis,et al.  Genetic Variants of GPX1 and SOD2 and Breast Cancer Risk at the Ontario Site of the Breast Cancer Family Registry , 2004, Cancer Epidemiology Biomarkers & Prevention.

[5]  A. Belgorosky,et al.  Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene. , 2003, The Journal of clinical endocrinology and metabolism.

[6]  J. Daling,et al.  Oral Contraceptives, Tubal Sterilization, and Functional Ovarian Cyst Risk , 2003, Obstetrics and gynecology.

[7]  I. Yang,et al.  Management of Ovarian Cysts in Women Undergoing Restorative Proctocolectomy for Ulcerative Colitis , 2003, The American surgeon.

[8]  John L Hopper,et al.  Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. , 2003, Journal of the National Cancer Institute.

[9]  P. Viganò,et al.  Endometriosis: novel etiopathogenetic concepts and clinical perspectives. , 2002, Fertility and sterility.

[10]  R. Homburg What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. , 2002, Human reproduction.

[11]  C. Bondy,et al.  Androgens and mammary growth and neoplasia. , 2002, Fertility and sterility.

[12]  R. Dickson,et al.  Roles of androgens in the development, growth, and carcinogenesis of the mammary gland , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  N. Boyd,et al.  Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies. , 2002, Annals of epidemiology.

[14]  L. Plouffe,et al.  The Effect of Selective Estrogen Receptor Modulators on Parameters of the Hypothalamic‐Pituitary‐Gonadal Axis , 2001, Annals of the New York Academy of Sciences.

[15]  I. Vauhkonen,et al.  Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. , 2001, The Journal of clinical endocrinology and metabolism.

[16]  H. Hollema,et al.  TAMOXIFEN TREATMENT AND GYNECOLOGIC SIDE EFFECTS: A REVIEW , 2001, Obstetrics and gynecology.

[17]  P. Vercellini,et al.  Ovarian and endometrial function during hormonal contraception. , 2001, Human reproduction.

[18]  C. Rao Does full-term pregnancy at a young age protect women against breast cancer through hCG? , 2000, Obstetrics and gynecology.

[19]  The prevalence of polycystic ovaries in women with a history of gestational diabetes , 2000, Clinical endocrinology.

[20]  R. Hirasing,et al.  Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. , 2000, Fertility and sterility.

[21]  R. Hoover,et al.  Tubal ligation and risk of breast cancer , 2000, British Journal of Cancer.

[22]  J. Russo,et al.  Hormonal approach to breast cancer prevention , 2000, Journal of cellular biochemistry. Supplement.

[23]  G. Giles,et al.  Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). , 1999, Journal of the National Cancer Institute. Monographs.

[24]  Polycystic ovaries and associated clinical and biochemical features in young women , 1999, Clinical endocrinology.

[25]  M. Cotterchio,et al.  The risk of breast cancer following reproductive surgery. , 1999, European journal of cancer.

[26]  U. Ekblad,et al.  Polycystic Ovaries in Women With Gestational Diabetes , 1998, Obstetrics and gynecology.

[27]  C. Berne,et al.  High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. , 1998, The Journal of clinical endocrinology and metabolism.

[28]  T. Sellers,et al.  Association of Stein‐Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa , 1997, Cancer.

[29]  E. Negri,et al.  Association of Stein‐Leventhal Syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa , 1997, Cancer.

[30]  Y. Ito,et al.  A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). , 1994, The Journal of clinical endocrinology and metabolism.

[31]  W. Thompson,et al.  Polycystic ovaries and the risk of breast cancer. , 1991, American journal of epidemiology.

[32]  C R Weinberg,et al.  The design and analysis of case-control studies with biased sampling. , 1990, Biometrics.

[33]  P. Wingo,et al.  Hysterectomy, tubal sterilization, and the risk of breast cancer. , 1988, American journal of epidemiology.

[34]  M. Rosner,et al.  Growth factors modify the epidermal growth factor receptor through multiple pathways , 1987, Journal of cellular biochemistry.

[35]  J. Annegers,et al.  Chronic Anovulation Syndrome and Associated Neoplasia , 1983, Obstetrics and gynecology.